MS unit5 (3)Comprehensive Study Notes on Cardiac Arrhythmias, Heart Blocks, and Electrical Interventions

Overview of Atrial Arrhythmias and Premature Atrial Contractions

Atrial arrhythmias originate in the upper two chambers of the heart (the atria). Five primary atrial arrhythmias require systematic identification and management.

• Premature Atrial Contraction (PAC)

  • Definition: An early cardiac depolarization occurring when the atria contract before the Sinoatrial (SA) node initiates its normal impulse.

  • ECG Characteristics:

  • Sudden shortening of the $R\text{-to-}R$ interval. The peak of the $R$ wave represents the highest point of the QRS complex.

  • Identification method: Drawing or marching out regular interval lines reveals a suddenly shortened distance between consecutive $R$ waves.

  • The QRS complex attempts to catch up following premature atrial depolarization.

  • Etiology: Triggered by underlying cardiac arrhythmias, cardiomegaly, hypoxia, or specific pharmacological agents.

  • Clinical Manifestations: Typically asymptomatic. When frequent, patients complain of heart palpitations.

  • Assessment Protocol: Evaluate cardiac strips using three systematic questions:

  1. Is the rhythm regular or irregular?

  2. Is there an identifiable P wave for every QRS complex?

  3. Is the $R\text{-to-}R$ interval suddenly shortened?

  • Treatment:

  • Asymptomatic or infrequent PACs require no medical intervention.

  • Frequent PACs are managed primarily with beta-blockers.

  • Mechanism of Beta-Blockers: Block beta-adrenergic receptors, reducing overall heart rate.

Atrial Flutter

Atrial flutter is characterized by rapid, regular atrial contractions that prevent adequate chamber filling prior to ventricular ejection.

• Pathophysiology: Rapid atrial squeezing occurs at an atrial rate of $250\text{--}350\,\text{beats/min}$.

• ECG Characteristics:

  • Multiple P waves preceding every QRS complex.

  • Distinctive sawtooth pattern (resembling an old-fashioned saw blade).

  • Overall heart rate is dictated by ventricular response; ventricular rate and output may remain normal if the AV node filters impulses.

  • Conduction pattern displays recurring sequences of multiple atrial contractions per single ventricular contraction (atrial, atrial, atrial, atrial, atrial, ventricular).

• Etiology: Pre-existing heart disease, heart failure, hypertension, and specific medications.

• Clinical Manifestations: Depend directly on ventricular rate.

  • Normal ventricular rate: Patients are often asymptomatic.

  • Elevated ventricular rate: Palpitations, angina (due to reduced diastolic filling time), and dyspnea.

• Treatment Interventions:

  • Primary Goal: Control ventricular rate.

  • Uncontrolled/Elevated Ventricular Rate: Synchronized cardioversion.

  • Controlled Ventricular Rate: Oral (PO) medications including calcium channel blockers or antiarrhythmic agents.

  • Procedural Intervention: Radiofrequency ablation of the right atrium to cauterize arrhythmogenic atrial tissue.

Atrial Fibrillation

Atrial fibrillation (AFib) involves chaotic, ineffective atrial electrical activity that mimics contraction on an ECG strip without producing mechanical atrial systole.

• Pathophysiology:

  • Atria quiver incoordinately instead of executing true contraction.

  • Complete absence of true P waves; baseline is rapid, chaotic, and fails to return to the isoelectric line.

  • The Atrioventricular (AV) node blocks the majority of chaotic atrial impulses from reaching the ventricles.

• Thromboembolism Risk:

  • Ineffective quivering leads to stasis of blood within the atria.

  • Stagnant blood aggregates clotting factors, forming thrombi.

  • Subsequent atrial contractions or turbulence dislodge clots into systemic arterial circulation.

  • History of AFib carries a high risk for ischemic stroke and embolic events.

• Clinical Features:

  • Paroxysmal or persistent (patients may slip in and out of AFib).

  • Physical Exam: Auscultation reveals absence of clear $S_1$ and $S_2$ heart sounds.

  • Symptoms: Shortness of breath (dyspnea), dizziness, syncope, and long-term progression to heart failure.

• Management Strategy:

  • Three Pillars of AFib Treatment:

  1. Control ventricular rate.

  2. Prevent thromboembolism.

  3. Restore normal sinus rhythm.

  • Unstable Patients: Immediate synchronized cardioversion.

  • Stable Patients: Ventricular rate control using beta-blockers or calcium channel blockers.

  • Anticoagulation: Lifelong oral anticoagulant therapy to eliminate clot risk.

  • Procedures: Catheter ablation targeting arrhythmogenic tissue.

Third-Degree Atrioventricular Block

Third-degree (Complete) Atrioventricular (AV) Block represents complete electrical dissociation between the atria and ventricles.

• Pathophysiology:

  • Electrical impulses generated by the SA node are completely blocked at the AV junction and fail to reach the ventricles.

  • Atria and ventricles beat independently driven by separate pacemakers.

  • Atria depolarize normally, but ventricular contraction depends on an intrinsic junctional or ventricular escape rhythm.

• ECG Characteristics:

  • Normal P waves occurring at a regular atrial rate.

  • Extremely slow ventricular rate with wide, bizarre QRS complexes due to altered ventricular conduction pathways.

• Etiology: Advanced conduction system disease or severe Digoxin toxicity.

  • Digoxin Toxicity Note: Discontinuing Digoxin resolves toxicity-induced complete heart block.

• Clinical Manifestations: Severe systemic hypoperfusion symptoms including altered mental status, confusion, dyspnea, and chest pain. Left untreated, complete block is fatal.

• Treatment:

  • Emergency temporary transcutaneous or transvenous cardiac pacing.

  • Definitive Treatment: Surgical implantation of a permanent pacemaker.

Premature Ventricular Contractions

Premature Ventricular Contractions (PVCs) originate from ectopic foci within the ventricles, causing premature depolarization prior to normal SA node signal arrival.

• ECG Characteristics:

  • Characterized by wide, bizarre QRS complexes and distorted T waves.

  • Unifocal PVCs: Arise from a single ectopic site, producing identical PVC morphology.

  • Multifocal PVCs: Arise from multiple ectopic sites, producing variable PVC shapes and distinct repeating patterns.

• Pattern Classification:

  • Bigeminy: Every second beat is a PVC (Normal beat, PVC, Normal beat, PVC).

  • Trigeminy: Every third beat is a PVC (Normal beat, Normal beat, PVC).

  • Quadrigeminy: Every fourth beat is a PVC (Normal beat, Normal beat, Normal beat, PVC).

• Etiology: High caffeine intake, alcohol ingestion, and electrolyte imbalances—specifically hypokalemia.

• Clinical Manifestations:

  • Infrequent: Asymptomatic or reported as a "skipped heart beat" sensation.

  • Frequent: Marked fatigue due to compromised diastolic filling time and reduced cardiac output. Frequent PVCs can trigger lethal ventricular dysrhythmias.

• Treatment:

  • Isolated/Infrequent PVCs: No medical treatment required.

  • Frequent PVCs ($>6\,\text{per minute}$): Pharmacotherapy including beta-blockers, calcium channel blockers, or antiarrhythmic agents.

Ventricular Tachycardia

Ventricular Tachycardia (V-tach) is a high-rate, potentially lethal dysrhythmia defined by three or more consecutive PVCs in sequence.

• Pathophysiology:

  • Continuous rapid ectopic firing of the ventricles without atrial coordination.

  • Ventricles lack sufficient filling time, causing severe drop in cardiac output and systemic tissue perfusion.

• ECG Characteristics:

  • Ventricular Rate: $150\text{--}250\,\text{beats/min}$.

  • Rapid, wide, bizarre QRS complexes.

  • Absence of visible P waves or T waves; baseline fails to reach the isoelectric line.

• Clinical Manifestations: Severe dyspnea, angina, rapid hemodynamic deterioration leading to pulselessness and loss of consciousness.

• Emergency Management:

  • V-tach with Pulse: Immediate administration of IV antiarrhythmic medications.

  • Pulseless V-tach:

  • Immediate High-Quality CPR.

  • Defibrillation.

  • Advanced Cardiac Life Support (ACLS): Endotracheal intubation, mechanical ventilation via bag-valve-mask (ambu bag), and ACLS resuscitation medications.

Ventricular Fibrillation

Ventricular Fibrillation (V-fib) is a chaotic rhythm representing uncoordinated, ineffective quivering of the ventricular myocardium.

• Pathophysiology: Total absence of organized ventricular depolarization, resulting in zero cardiac output.

• ECG Characteristics: Chaotic, irregular baseline spikes without identifiable P waves, QRS complexes, or T waves.

• Clinical Presentation:

  • Immediate loss of consciousness and unresponsiveness.

  • Absence of palpable pulses, audible heart sounds, or measurable blood pressure.

  • Respiratory arrest, cyanosis, and fixed, dilated pupils.

• Emergency Treatment:

  • Rule: "Defib the V-fib" — Immediate electrical defibrillation is mandatory.

  • Cardiopulmonary resuscitation (CPR).

  • Intubation and Advanced Cardiac Life Support (ACLS) protocol implementation.

Asystole

Asystole represents the complete cessation of electrical and mechanical activity within the heart ("flatline").

• Pathophysiology: Total absence of electrical impulses from any cardiac pacemaker site; complete cardiac standstill.

• ECG Characteristics: Flat line showing zero electrical activity.

• Comparison to V-fib:

  • V-fib displays chaotic electrical activity and responds to electrical shock.

  • Asystole lacks electrical activity entirely; asystole cannot be shocked.

• Clinical Presentation: Unconscious, unresponsive, apnoeic, pulseless, with absent blood pressure and heart sounds.

• Treatment Protocol:

  • Immediate High-Quality CPR.

  • Endotracheal intubation.

  • ACLS protocol: Administration of IV epinephrine and vasopressors to stimulate electrical cardiac activity (Defibrillation is ineffective and contraindicated).

Pacemakers, Implantable Cardioverter Defibrillators, and ECG Pacer Spikes

Cardiothoracic electrical devices maintain heart rate stability or deliver high-energy shocks during lethal rhythms.

• Device Classifications:

  • Pacemaker: Maintains cardiac rhythm by sending low-energy electrical impulses when intrinsic heart rate falls below set thresholds.

  • Implantable Cardioverter Defibrillator (ICD): Monitors cardiac rhythm continuously and delivers high-energy electrical shocks to terminate lethal ventricular dysrhythmias (V-tach/V-fib).

  • Dual Devices: Combined unit featuring both pacing and internal defibrillation capabilities.

• ECG Pacer Spike Identification:

  • A pacer spike appears as a sharp, vertical line on the rhythm strip indicating artificial electrical depolarization.

  • Atrial Pacemaker: Pacer spike appears immediately preceding the P wave.

  • Ventricular Pacemaker: Pacer spike appears immediately preceding or within the QRS complex.

  • Dual-Chamber Pacemaker: Distinct pacer spikes appear before both the P wave and the QRS complex.

Comparison of Defibrillation, Cardioversion, and AEDs

Understanding non-invasive and invasive electrical therapeutic devices is essential for arrhythmia management.

• Defibrillation: Unsynchronized high-energy delivery used in pulseless emergency situations (Pulseless V-tach and V-fib).

• Synchronized Cardioversion: Timed electrical shock delivered on the $R$ wave of the QRS complex to prevent shocking during the vulnerable refractory period (T wave); used for unstable tachydysrhythmias with a pulse (e.g., AFib, Atrial Flutter, V-tach with pulse).

• Automated External Defibrillator (AED): Portable external device that automatically analyzes cardiac rhythm and prompts the operator to deliver a shock if a shockable rhythm (V-fib or pulseless V-tach) is detected.